Integrated Diagnostics (UK) Analysis
| IDHC Stock | 0.47 0.01 2.17% |
Integrated Diagnostics Holdings is overvalued with Real Value of 0.38 and Hype Value of 0.45. The main objective of Integrated Diagnostics stock analysis is to determine its intrinsic value, which is an estimate of what Integrated Diagnostics Holdings is worth, separate from its market price. There are two main types of Integrated Diagnostics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Integrated Diagnostics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Integrated Diagnostics' stock to identify patterns and trends that may indicate its future price movements.
The Integrated Diagnostics stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Integrated Diagnostics is usually not traded on Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, May Day Bank Holiday, Spring Bank Holiday ( 2025 ). Integrated Stock trading window is adjusted to Europe/London timezone.
Integrated |
Integrated Stock Analysis Notes
About 34.0% of the company shares are held by company insiders. The book value of Integrated Diagnostics was currently reported as 4.64. The company last dividend was issued on the 16th of June 2022. Integrated Diagnostics had 4:1 split on the 24th of December 2020. To learn more about Integrated Diagnostics Holdings call the company at 44 15 3484 7000 or check out https://www.idhcorp.com.Integrated Diagnostics Quarterly Total Revenue |
|
Integrated Diagnostics Investment Alerts
| Integrated Diagnostics has some characteristics of a very speculative penny stock | |
| Integrated Diagnostics had very high historical volatility over the last 90 days | |
| About 34.0% of the company shares are held by company insiders |
Integrated Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 27.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Integrated Diagnostics's market, we take the total number of its shares issued and multiply it by Integrated Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Integrated Profitablity
Integrated Diagnostics' profitability indicators refer to fundamental financial ratios that showcase Integrated Diagnostics' ability to generate income relative to its revenue or operating costs. If, let's say, Integrated Diagnostics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Integrated Diagnostics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Integrated Diagnostics' profitability requires more research than a typical breakdown of Integrated Diagnostics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16. Management Efficiency
Integrated Diagnostics has return on total asset (ROA) of 0.0969 % which means that it generated a profit of $0.0969 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2303 %, meaning that it generated $0.2303 on every $100 dollars invested by stockholders. Integrated Diagnostics' management efficiency ratios could be used to measure how well Integrated Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Integrated Diagnostics' Other Current Assets are comparatively stable compared to the past year. Other Assets is likely to gain to about 9.6 M in 2025, whereas Total Assets are likely to drop slightly above 4.1 B in 2025.Leadership effectiveness at Integrated Diagnostics Holdings is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 12th of January 2025, Integrated Diagnostics retains the Market Risk Adjusted Performance of (0.79), downside deviation of 4.05, and Risk Adjusted Performance of 0.0697. Integrated Diagnostics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Integrated Diagnostics maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk to decide if Integrated Diagnostics is priced fairly, providing market reflects its last-minute price of 0.47 per share.Integrated Diagnostics Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Integrated Diagnostics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Integrated Diagnostics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Integrated Diagnostics Outstanding Bonds
Integrated Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Integrated Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Integrated bonds can be classified according to their maturity, which is the date when Integrated Diagnostics Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Integrated Diagnostics Predictive Daily Indicators
Integrated Diagnostics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Integrated Diagnostics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Integrated Diagnostics Forecast Models
Integrated Diagnostics' time-series forecasting models are one of many Integrated Diagnostics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Integrated Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Integrated Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Integrated Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Integrated shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Integrated Diagnostics. By using and applying Integrated Stock analysis, traders can create a robust methodology for identifying Integrated entry and exit points for their positions.
Integrated Diagnostics is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Integrated Diagnostics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.